Literature DB >> 15026560

Linkage of myostatin pathway genes with knee strength in humans.

W Huygens1, M A Thomis, M W Peeters, J Aerssens, R Janssen, R F Vlietinck, G Beunen.   

Abstract

This study was the first to explore the potential role of the myostatin (GDF8) pathway in relation to muscle strength and estimated muscle cross-sectional area in humans using linkage analysis with a candidate gene approach. In young male sibs (n = 329) 11 polymorphic markers in or near 10 candidate genes from the myostatin pathway were genotyped. Muscle mass was estimated by anthropometric measurements, and maximal knee strength was evaluated using isokinetic dynamometers (Cybex NORM). Single-point nonparametric variance components and linear quantitative trait locus regression linkage analysis methods were used. Linkage patterns were observed between knee extension and flexion peak torque with markers D2S118 (GDF8), D6S1051 (CDKN1A), and D11S4138 (MYOD1), and a maximum LOD score of 2.63 (P = 0.0002) was observed with D2S118. The ratios of peak torque over muscle and bone area of the midthigh of the lower contraction velocity (60 degrees/s) showed more frequently significant LOD scores than the torques at high velocity (240 degrees/s). Although myostatin is physiologically more related to muscle mass through possible effects of hyperplasia and hypertrophy than it is to strength, only two estimated muscle cross-sectional areas were marginally linked (LOD 1.06 and 1.07, P = 0.01) with marker D2S118 near GDF8 (2q32.2). The present results gave suggestive evidence that the myostatin pathway might be important for strength phenotypes, and GDF8, CDKN1A, and MYOD1 are potential candidate regions for a further and denser mapping with respect to these phenotypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026560     DOI: 10.1152/physiolgenomics.00224.2003

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  24 in total

1.  The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan.

Authors:  Marta González-Freire; Gabriel Rodríguez-Romo; Catalina Santiago; Natalia Bustamante-Ara; Thomas Yvert; Félix Gómez-Gallego; José A Serra Rexach; Jonatan R Ruiz; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2010-03-23

2.  Gene driven power athletes? Genetic variation in muscular strength and power.

Authors:  G Beunen; M Thomis
Journal:  Br J Sports Med       Date:  2006-10       Impact factor: 13.800

3.  Identification and prioritization of NUAK1 and PPP1CC as positional candidate loci for skeletal muscle strength phenotypes.

Authors:  An Windelinckx; Gunther De Mars; Wim Huygens; Maarten W Peeters; Barbara Vincent; Cisca Wijmenga; Diether Lambrechts; Jeroen Aerssens; Robert Vlietinck; Gaston Beunen; Martine A I Thomis
Journal:  Physiol Genomics       Date:  2011-07-12       Impact factor: 3.107

4.  Genome-wide linkage scan for contraction velocity characteristics of knee musculature in the Leuven Genes for Muscular Strength Study.

Authors:  Gunther De Mars; An Windelinckx; Wim Huygens; Maarten W Peeters; Gaston P Beunen; Jeroen Aerssens; Robert Vlietinck; Martine A I Thomis
Journal:  Physiol Genomics       Date:  2008-08-05       Impact factor: 3.107

Review 5.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 6.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 7.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

8.  Is there an optimum endurance polygenic profile?

Authors:  Jonatan R Ruiz; Félix Gómez-Gallego; Catalina Santiago; Marta González-Freire; Zoraida Verde; Carl Foster; Alejandro Lucia
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

9.  Association of the K153R polymorphism in the myostatin gene and extreme longevity.

Authors:  Nuria Garatachea; Tomàs Pinós; Yolanda Cámara; Gabriel Rodríguez-Romo; Enzo Emanuele; Giovanni Ricevuti; Letizia Venturini; Alejandro Santos-Lozano; Catalina Santiago-Dorrego; Carmen Fiuza-Luces; Thomas Yvert; Antoni L Andreu; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2013-01-25

Review 10.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.